CORAL Clinical Trial Overview: Chronic Cough Reduction for Patients with IPF 

In this educational video, Dr. Émilie Millaire provides an overview of Trevi Therapeutic’s CORAL Phase II clinical trial on chronic cough relating to idiopathic pulmonary fibrosis (IPF).
Learn about previous CANAL Phase II clinical trial results, how to participate in the upcoming CORAL trial if you have idiopathic pulmonary fibrosis, and what to expect.
Find more pulmonary fibrosis clinical trial resources: cpff.ca/patients-and-caregivers/pf-resource-library/#clinical
Learn more about pulmonary fibrosis research and healthcare providers: cpff.ca/research-and-healthcare-providers/
Dr. Bio:
Dr. Émilie Millaire, MD, is a Respirologist at the Mauricie Respiratory Clinic (CRM), serving as the Medical Director of the Mauricie Clinical Investigation Center and the Medical Co-Director of the CRM’s first complete pulmonary readaptation program. Dr. Millaire has extensive education in pulmonology and is a principal investigator in clinical PF research with published works on the progression of PF and ILD.